ChemicalBook > CAS DataBase List > Benzonitrile, 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]-
Benzonitrile, 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]-
- Product Name
- Benzonitrile, 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]-
- CAS No.
- 2097262-58-1
- Chemical Name
- Benzonitrile, 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]-
- Synonyms
- TVB-3664;TVB-3664 ，S8563;TVB-3664 Benzonitrile,;TVB-3664, 10 mM in DMSO;TVB3664,Inhibitor,TVB 3664,TVB-3664,Fatty Acid Synthase (FASN),inhibit;4-(1-(5-(4-(Methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-5-yl)-2,4-dimethylbenzoyl)azetidin-3-yl)benzonitrile;4-[1-[5-[5-(Methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]benzonitrile;4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]azetidin-3-yl]benzonitrile;Benzonitrile, 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]-
- CBNumber
- CB35431871
- Molecular Formula
- C25H23F3N4O2
- Formula Weight
- 468.47
- MOL File
- 2097262-58-1.mol
More
Less
Benzonitrile, 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]- Property
- Boiling point:
- 665.7±55.0 °C(Predicted)
- Density
- 1.36±0.1 g/cm3(Predicted)
- pka
- 9.61±0.10(Predicted)
- form
- Solid
- color
- White to off-white
- InChI
- InChI=1S/C25H23F3N4O2/c1-14-8-15(2)20(9-19(14)22-21(13-34-3)30-24(31-22)25(26,27)28)23(33)32-11-18(12-32)17-6-4-16(10-29)5-7-17/h4-9,18H,11-13H2,1-3H3,(H,30,31)
- InChIKey
- YFEOVRCUSPPGFZ-UHFFFAOYSA-N
- SMILES
- C(#N)C1=CC=C(C2CN(C(=O)C3=CC(C4=C(COC)NC(C(F)(F)F)=N4)=C(C)C=C3C)C2)C=C1
More
Less
N-Bromosuccinimide Price
ChemScene
- Product number
- CS-0069413
- Product name
- TVB-3664
- Purity
- 99.66%
- Packaging
- 5mg
- Price
- $420
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-0069413
- Product name
- TVB-3664
- Purity
- 99.66%
- Packaging
- 25mg
- Price
- $1250
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-0069413
- Product name
- TVB-3664
- Purity
- 99.66%
- Packaging
- 100mg
- Price
- $3000
- Updated
- 2021/12/16
Chemenu
- Product number
- CM328374
- Product name
- 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]azetidin-3-yl]benzonitrile
- Purity
- 95%+
- Packaging
- 1g
- Price
- $6633
- Updated
- 2021/12/16
DC Chemicals
- Product number
- 020568
- Product name
- TVB-3664
- Packaging
- 001
- Price
- $1500
- Updated
- 2021/12/16
More
Less
Benzonitrile, 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]- Chemical Properties,Usage,Production
Uses
TVB-3664 is an orally available, reversible, potent, selective and highly bioavailable fatty acid synthase (FASN) inhibitor, with IC50 values of 18 nM and 12 nM for human and mouse cell palmitate synthesis, respectively. TVB-3664 significantly reduces tubulin palmitoylation and mRNA expression[1][2].
in vivo
TVB-3664 (3 mg/kg (Pt 2614 and Pt 2449PT) or 6 mg/kg (Pt 2402 and Pt 2449LM), oral gavage, daily, 4 weeks) treatment leads to a significant reduction in tumor volume and tumor weight in Pt 2614, Pt 2449PT, and Pt 2402 PDX models, with an average reduction in tumor weight of 30%, 37.5% and 51.5%, respectively[1].
| Animal Model: | Colorectal cancer (CRC) PDX models in NOD-SCID-IL2rg-/- (NSG) mice using specimens collected from patients who had undergone surgery for resection of primary CRC or CRC metastasis[1]. |
| Dosage: | 3 mg/kg (Pt 2614 and Pt 2449PT) or 6 mg/kg (Pt 2402 and Pt 2449LM). |
| Administration: | Oral gavage daily for 4 weeks. |
| Result: | Led to a significant reduction in tumor volume and tumor weight in Pt 2614, Pt 2449PT, and Pt 2402 PDX models, with an average reduction in tumor weight of 30%, 37.5% and 51.5%, respectively. |
References
[1] Zaytseva YY, et al. Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer. Oncotarget. 2018 May 15;9(37):24787-24800. DOI:10.18632/oncotarget.25361
[2] Heuer TS, et al. FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression. EBioMedicine. 2017 Feb;16:51-62. DOI:10.1016/j.ebiom.2016.12.012
Benzonitrile, 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]- Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Benzonitrile, 4-[1-[5-[5-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-2,4-dimethylbenzoyl]-3-azetidinyl]- Suppliers
- Tel
- 18096409024
- sales02@foreversyn.com
- Country
- China
- ProdList
- 1961
- Advantage
- 58
- Tel
- 021-58170097
- info@topbiochem.com
- Country
- China
- ProdList
- 9510
- Advantage
- 58
- Tel
- 18149758185
- sales-cpd@caerulumpharma.com
- Country
- China
- ProdList
- 3506
- Advantage
- 58
- Tel
- +86 13524779951; 13524779951
- Fax
- QQ: 2075692521
- 2075692521@qq.com
- Country
- China
- ProdList
- 298
- Advantage
- 55
- Tel
- 021-52996696，15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4768
- Advantage
- 55
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 021-31433387 15618786686
- Fax
- QQ:1369748377
- sales@rechemscience.com
- Country
- China
- ProdList
- 2991
- Advantage
- 58
- Tel
- 0550-5196001 15000891977
- Fax
- 0550-5196001
- wj520wjxby@126.com
- Country
- China
- ProdList
- 1944
- Advantage
- 55
- Tel
- 18096642264
- sales@foreversyn.com
- Country
- China
- ProdList
- 492
- Advantage
- 58
- Tel
- +1-2135480471
- sales@sarms4muscle.com
- Country
- China
- ProdList
- 10473
- Advantage
- 58